Effect of Serum Interleukin-6 Concentration on the Prognosis After Radiotherapy for Patients With Hepatocellular Carcinoma

Effect of Serum Interleukin-6 Concentration on the Prognosis After Radiotherapy for Patients With Hepatocellular Carcinoma

Conclusions: The prognosis of HCC patients receiving RT was worse for those with a pre-RT serum IL-6 concentration > 7.8 pg/mL than those with a pre-RT serum IL-6 concentration ≤ 7.8 pg/mL. Pre-RT IL-6 concentrations may affect the prognosis of HCC patients.

Saved in:

Bibliographic Details
Main Authors:	Yong Hu, Yongkang Zhou, Shisuo Du, Wenchao Zhu, Yixing Chen, Zhaochong Zeng
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/cjgh/4696097
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling
by: Zongjuan Li, et al.
Published: (2022-12-01)

Metformin reverses 5-FU resistance induced by radiotherapy through mediating folate metabolism in colorectal cancer
by: Shuxuan Wang, et al.
Published: (2025-05-01)

The impact of early peroral feeding on concentration of the serum interleukin–6 in patients after pancreaticoduodenectomy
by: A. V. Skums, et al.
Published: (2020-05-01)

Association between Serum Interleukin-6 Concentration and Mortality in Patients with Coronary Artery Disease
by: Dongfang Su, et al.
Published: (2013-01-01)

Interrelation of the dynamics of serum concentrations of interleukin-1β, interleukin-6 and interleukin-10 with clinical data in acute ischemic stroke and the strategy of reperfusion therapy
by: A. Yu. Bykova, et al.
Published: (2020-01-01)

Efficacy and factors related to prognosis of combination chemotherapy with different radiotherapy methods in patients with unresectable hepatocellular carcinoma
by: Lian-Qiang Han
Published: (2025-04-01)

A non-invasive nomogram for the prediction of poor prognosis of hepatocellular carcinoma based on the novel marker Interleukin-41
by: Zihan Mu, et al.
Published: (2025-05-01)

Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis
by: Li Yuan, et al.
Published: (2025-04-01)

Evaluation of serum hsa_tsr014055 as a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma
by: Jing Xu, et al.
Published: (2025-12-01)

Independent role of interleukin interleukin-6 and interleukin-8 in the etiology of transfusion reactions to platelet concentrates in children
by: Šerbić-Nonković Olivera, et al.
Published: (2018-01-01)

Detection of interleukin-6 and interleukin-8 in serum from women with recurrent spontaneous abortion
by: Baghdad Science Journal
Published: (2010-09-01)

Co-adjuvant nano particles for hepatocellular carcinoma radiotherapy treatment
by: Ramy Sabry Abd-Elsamee, et al.
Published: (2025-06-01)

CAT and CXCL8 are crucial cofactors for the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma, the immune infiltration and prognosis of hepatocellular carcinoma
by: Liang Yang, et al.
Published: (2025-03-01)

Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma
by: Su-xia Han, et al.
Published: (2014-01-01)

Interleukin-27 levels and its Polymorphism in Hepatocellular carcinoma associated with Hepatitis C
by: Nahla Anber, et al.
Published: (2020-02-01)

RNA m6A methylation patterns in hepatocellular carcinoma and their association with characteristics of the tumor microenvironment and prognosis
by: Zongcai Yan, et al.
Published: (2025-06-01)

The use of artificial intelligence in stereotactic ablative body radiotherapy for hepatocellular carcinoma
by: Atsuto Katano
Published: (2025-06-01)

The impact of radiotherapy on the prognosis of metastatic clear cell renal cell carcinoma after surgery
by: Xuwen Li, et al.
Published: (2025-05-01)

and as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2017-07-01)

Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis
by: Fengle Jiang, et al.
Published: (2025-01-01)

Serum concentrations of interleukin-6 and tumor necrosis factor alpha in patients with spondyloarthritis: a relationship between systemic inflammation and anemia
by: К. N. Safarova, et al.
Published: (2022-07-01)

Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma
by: Song Z, et al.
Published: (2025-05-01)

Incidence, Characteristics, and Prognosis of Incidentally Discovered Hepatocellular Carcinoma after Liver Transplantation
by: Walid El Moghazy, et al.
Published: (2016-01-01)

Determining the gross tumor volume for hepatocellular carcinoma radiotherapy based on multi-phase contrast-enhanced magnetic resonance imaging
by: Kangning Meng, et al.
Published: (2025-01-01)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
by: Cheng‐Qian Zhong, et al.
Published: (2018-06-01)

Prediction of Prognosis in Patients with Hepatocellular Carcinoma Based on Molecular Subtypes of Immune Genes
by: Suming Du, et al.
Published: (2022-01-01)

GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma
by: Ting Liu, et al.
Published: (2017-06-01)

The Significance of Serum and Fecal Levels of Interleukin-6 and Interleukin-8 in Hospitalized Children with Acute Rotavirus and Norovirus Gastroenteritis
by: Shan-Ming Chen, et al.
Published: (2014-04-01)

Risk Factors of Non-Classic Radiation-Induced Liver Disease (ncRILD) After Intensity-Modulated Radiotherapy in Hepatocellular Carcinoma
by: Du YQ, et al.
Published: (2025-06-01)

The Expression of Ferroptosis-Related Genes in Hepatocellular Carcinoma and Their Relationships With Prognosis
by: Li H, et al.
Published: (2025-03-01)

Mechanisms of HRAS regulation of liver hepatocellular carcinoma for prognosis prediction
by: Xingbao Fang, et al.
Published: (2025-04-01)

MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis
by: Xiao-Ying Huang, et al.
Published: (2013-01-01)

Serum Concentrations of Interleukin-8 and Vitamin D Levels in Jordanian Patients with Rheumatoid Arthritis
by: Ali deeb AS, et al.
Published: (2025-07-01)

Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics.
by: Sunmin Park, et al.
Published: (2025-01-01)

Association of Serum Adropin Concentrations with Diabetic Nephropathy
by: Wenchao Hu, et al.
Published: (2016-01-01)

Diagnostic value of serum levels of interleukin-9,interleukin-18 and interleukin-32 in patients with multiple myeloma
by: Zhuang Ni-la, et al.
Published: (2021-01-01)

Preoperative Serum Glycan Levels Reflect Progression of Patients With Hepatocellular Carcinoma
by: Sheng‐Sheng Liu, et al.
Published: (2024-10-01)

Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study
by: Su K, et al.
Published: (2025-05-01)

Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk
by: Wei Shen, et al.
Published: (2025-07-01)

The practicality of interleukin-6 in prognosis of blunt chest trauma in Korea: a retrospective study
by: Jeong Woo Oh, et al.
Published: (2023-06-01)